Prevalence of dyslipidemic risk factors in hemodialysis and CAPD patients
- 1 May 2003
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 63 (84) , S113-S116
- https://doi.org/10.1046/j.1523-1755.63.s84.23.x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Importance of hyperlipidaemia and therapy in renal patientsNephrology Dialysis Transplantation, 2000
- Low apolipoprotein A-IV plasma concentrations in men with coronary artery diseaseJournal of the American College of Cardiology, 2000
- The Low Molecular Weight Apo(a) Phenotype Is an Independent Predictor for Coronary Artery Disease in Hemodialysis PatientsJournal of the American Society of Nephrology, 1999
- Clinical epidemiology of cardiovascular disease in chronic renal diseaseAmerican Journal of Kidney Diseases, 1998
- Atherosclerosis and arteriosclerosis in chronic renal failureKidney International, 1997
- Protection Against Atherogenesis in Mice Mediated by Human Apolipoprotein A-IVScience, 1996
- Lipoprotein(a) in renal diseaseAmerican Journal of Kidney Diseases, 1996
- Lipid abnormalities in renal diseaseKidney International, 1991
- The role of apolipoprotein A-IV in reverse cholesterol transport studied with cultured cells and liposomes derived from an ether analog of phosphatidylcholineBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986
- Plasma cholesterol metabolism in end-stage renal disease. Difference between treatment by hemodialysis or peritoneal dialysis.Journal of Clinical Investigation, 1986